LCLi-Zhi Cheng

Li-Zhi Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Li-Zhi Cheng has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Zhou

    State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China

    1 shared publication
  • Dan‐Ling Huang

    Institute for Inheritance‐Based Innovation of Chinese Medicine, School of Pharmaceutical Sciences Shenzhen University Health Science Center Shenzhen China

    1 shared publication
  • Jiang Zeng-Rong

    Department of System Engineering and Mathematics, National University of Defense Technology, Changsha, Hunan, China

    1 shared publication
  • Jia‐Hao Zhang

    State Key Laboratory of Natural Medicines, Department of Pharmacology, School of Pharmacy China Pharmaceutical University Nanjing China

    1 shared publication
  • Man Dou

    State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, PR China; Faculty of Life Science and Engineering, Kunming University of Science and Technology, Kunming, 650500, PR China

    1 shared publication
  • Nai‐Xia Zhang

    State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China

    1 shared publication

Latest Publications

  • Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer

    by Li‐Zhi Cheng, Dan‐Ling Huang, Zhang‐Rui Tang, Jia‐Hao Zhang, Ting Xiong, Chen Zhou, Nai‐Xia Zhang, Rong Fu, Yong‐Xian Cheng, Zhao‐Qiu Wu

    Background and Purpose: The scaffold molecule Axin2 is constitutively activated in colorectal cancer (CRC) and functions as a potent promoter of CRC behaviour. Pharmacological targeting of Axin2 may therefore exert a therapeutic effect in patients with CRC. Here, we discovered a potent small‐molecule inhibitor of Axin2, based on the mechanism by which Axin2 is regulated post‐translationally, and investigated its antitumour effects.Experimental Approach: Compound discovery and its inhibitory action on Axin2 protein were revealed by microscale thermophoresis, in vitro kinase assay, quantitative kinetic assay, immunoblotting/immunoprecipitation, RT‐qPCR and cycloheximide pulse‐chase assay. Compound antitumour effects and the underlying mechanisms were evaluated in multiple cell‐based assays and mouse models.Key Results: We discovered that glycogen synthase kinase 3β (GSK3β) phosphorylates Axin2 at two consensus motifs and coupled Axin2 phosphorylation to its ubiquitination (mediated by the E3 ligase β‐Trcp2) and proteasomal degradation. The binding of Axin2 to GSK3β in CRC cells is faint, which enables most of the Axin2 protein to maintain an unphosphorylated status and thereby permits the cells to preserve high levels of Axin2. Importantly, we identified a small‐molecule compound CW85319 that enhances Axin2's interaction with GSK3β via forming a high affinity for Axin2. Treatment of CRC cells with CW85319 enhanced Axin2 binding with GSK3β, thereby promoting Axin2 phosphorylation, subsequent ubiquitination, and degradation. Furthermore, we demonstrated that CW85319 efficiently suppressed Axin2‐driven CRC growth and metastasis, without eliciting side toxicity.Conclusions and Implications: These findings suggest that pharmacological targeting of Axin2 by CW85319 may provide therapeutic benefits against certain human cancers, especially CRC.


  • Racemic alkaloids from the fungus Ganoderma cochlear

    by Xin-Long Wang, Man Dou, Qi Luo, Li-Zhi Cheng, Yong-Ming Yan, Rong-Tao Li, Yong-Xian Cheng


  • Real transform algorithm for computing discrete circular deconvolution

    by Cheng Li-Zhi, Tong Li, Jiang Zeng-Rong

    Fast computation of the discrete deconvolution is very important in image/video signal processing. We develop a real transform algorithm for calculating the discrete circular deconvolution by substituting the fast Fourier transform (FFT) defined in the complex domain. It is shown that the computational cost of the algorithm is about half of the traditional FFT. Furthermore, the algorithm has a weak numerical stability.